A012303: ShortStop-HER2

Study Details

Full Title

Protocol A012303, ShortStop-HER2: Shortened duration of adjuvant therapy in patients with early-stage HER2+ breast cancer who achieve pCR after neoadjuvant chemotherapy with HER2 blockade.

Principal Investigator

Neha
Verma

Protocol Number

PRO00119313

NCT ID

NCT06876714

Phase

III

Enrollment Status

Open to Enrollment